Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ensysce Biosciences, Inc. - Common Stock (NQ:ENSC)

2.030 -0.100 (-4.69%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ensysce Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Why Ensysce Biosciences Stock Is Exploding Higher During Wednesday's Session
Ensysce Biosciences Inc (NASDAQ: ENSC) shares are trading higher by 21.81% to $0.82 Wednesday after the company announced initiation of the final stage of its opioid overdose protection Phase 1 study.... 
Via Benzinga
Nasdaq Falls 50 Points; eHealth Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 50 points on Wednesday. The Dow traded down 0.12% to 33,694.64 while the NASDAQ fell 0.44% to 11,284.18.... 
Via Benzinga
Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products. 
Via Benzinga
Ensysce Biosciences Announces Initiation of Final Stage of Groundbreaking Opioid Overdose Protection Phase 1 Study
Via ACCESSWIRE
Ensysce Biosciences Announces Successful Completion of Clinical Portion of Oral Human Abuse Potential Trial
Via ACCESSWIRE
Ensysce Biosciences's Return On Capital Employed Overview
 
Via Benzinga
Nasdaq Down Over 200 Points; AT&T Posts Upbeat Earnings
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Wednesday. The Dow traded down 1.10% to 33,364.09 while the NASDAQ fell 1.92% to 11,116.96.... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Ensysce Biosciences to Present at Diamond Equity Research 2023 Virtual Emerging Growth Invitational
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Ensysce Biosciences Announces Data from PF614-MPAR-101-Part A Successfully Demonstrating Opioid Overdose Protection
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Ensysce Biosciences Issues 2023 Shareholder Letter
Via ACCESSWIRE
Analyzing Ensysce Biosciences's Short Interest
Ensysce Biosciences's (NASDAQ:ENSC) short percent of float has fallen 83.99% since its last report. The company recently reported that it has 143 thousand shares sold short, which is 2.6% of all... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  OnFriday, 143 stocks hit new 52-week lows. 
Via Benzinga
How Is The Market Feeling About Ensysce Biosciences?
Ensysce Biosciences's (NASDAQ:ENSC) short percent of float has risen 128.73% since its last report. The company recently reported that it has 315 thousand shares sold short, which is 16.24% of all... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 115 stocks hit new 52-week lows. 
Via Benzinga
Why Aptevo Therapeutics Shares Are Trading Higher By More Than 100%; Here Are 28 Stocks Moving Premarket
Gainers 
Via Benzinga
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate. 
Via Benzinga
Dow Edges Higher; Prometheus Biosciences Shares Jump
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 0.5% on Wednesday. 
Via Benzinga
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Nasdaq Drops 75 Points; Crude Oil Down 2%
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping 75 points on Wednesday. 
Via Benzinga
What In The World Is Going On With Ensysce Biosciences Stock?
Ensysce Biosciences Inc (NASDAQ: ENSC) shares are trading lower by 51.12% to $1.09 Wednesday morning after the comnpany announced pricing of a $4.1 million public offering. What Happened? 
Via Benzinga
US Stocks Mixed; Dow Rises 50 points
U.S. stocks traded mixed this morning, with the Dow Jones gaining more than 50 points on Wednesday. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.